Goodwill and Intangible Assets

12 Months Ended

Dec. 31, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

The changes in the carrying amount of goodwill by reportable segment were as follows:



($ in millions)	Proprietary Products			Contract-Manufactured Products			Total
Balance, December 31, 2015	$	75.1		$	29.5		$	104.6
Foreign currency translation	(1.4		)	(0.2		)	(1.6		)
Balance, December 31, 2016	73.7			29.3			103.0
Foreign currency translation	3.9			0.8			4.7
Balance, December 31, 2017	$	77.6		$	30.1		$	107.7

As of December 31, 2017, we had no accumulated goodwill impairment losses.

Intangible assets and accumulated amortization as of December 31 were as follows:



	2017							2016
($ in millions)	Cost		Accumulated Amortization			Net		Cost		Accumulated Amortization			Net
Patents and licensing	$	18.2	$	(14.1	)	$	4.1	$	17.8	$	(13.4	)	$	4.4
Technology	3.3		(1.0		)	2.3		3.3		(0.7		)	2.6
Trademarks	2.0		(1.7		)	0.3		2.0		(1.6		)	0.4
Customer relationships	29.3		(19.1		)	10.2		29.3		(18.3		)	11.0
Customer contracts	11.1		(6.3		)	4.8		10.7		(5.8		)	4.9
	$	63.9	$	(42.2	)	$	21.7	$	63.1	$	(39.8	)	$	23.3

The cost basis of intangible assets includes a foreign currency translation gain of $0.9 million and a foreign currency translation loss of $0.3 million for the years ended December 31, 2017 and 2016, respectively. Amortization expense for the years ended December 31, 2017, 2016 and 2015 was $2.4 million, $2.6 million and $3.5 million, respectively. Estimated annual amortization expense for the next five years is as follows: 2018 - $2.2 million, 2019 - $2.2 million, 2020 - $2.1 million, 2021 - $2.1 million and 2022 - $2.1 million. During 2016, as part of our restructuring plan, we recorded within other expense a $2.8 million non-cash asset write-down associated with the discontinued use of a patent and a $10.0 million non-cash asset write-down associated with the discontinued use of an indefinite-lived trademark.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details